Novacyt S.A. (CDI) (NCYT)

Sector:

Health Care

Index:

FTSE AIM 100

325.50p
   
  • Change Today:
      2.50p
  • 52 Week High: 1,194.00
  • 52 Week Low: 285.00
  • Currency: UK Pounds
  • Shares Issued: 70.63m
  • Volume: 245,867
  • Market Cap: £229.89m
  • RiskGrade: 453

NCYT Overview

The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 60.4% 28.1%
ROCE 126.9%  
Latest F'cast
P/E 1.7 5.9
PEG n/a n/a
Pr/Revenue 0.8 1.8
Pr/Book 1.5  
Latest F'cast
Revenue 2316.7% -45.2%
PBT n/a -74.2%
EPS n/a -65.4%
DPS n/a n/a

NCYT Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 11.08 (5.71) (47.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 12.75 (3.49) (15.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-18 13.72 (2.08) (6.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-19 11.47 (3.43) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-20 277.20 165.17 194.00p 4.4 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

NCYT Forecasts

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 129.70 36.40 67.13¢ 5.7 n/a -65% n/a 0.0%
31-Dec-22 79.90 28.10 29.01¢ 13.2 n/a -57% n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

NCYT Company Announcements

David Allmond to be CEO, Graham Mullis to retire 29-Jul-2021 07:00 RNS
Director/PDMR Shareholding 06-Jul-2021 14:40 RNS
Liquidity Agreement and Total Voting Rights 01-Jul-2021 14:30 RNS

NCYT ShareCast News

Novacyt appoints David Allmond as new chief exec... 29-Jul-2021 ShareCast
Novacyt launches two new rapid Covid-19 test pro... 29-Jun-2021 ShareCast
Novacyt swings to huge profit after pivot to Cov... 22-Jun-2021 ShareCast

Latest NCYT Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

NCYT Market Data

Currency UK Pounds
Share Price 325.50p
Change Today 2.50p
% Change 0.77 %
52 Week High 1,194.00
52 Week Low 285.00
Volume 245,867
Shares Issued 70.63m
Market Cap £229.89m
RiskGrade 453

NCYT Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
89.70% above the market average89.70% above the market average89.70% above the market average89.70% above the market average89.70% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average
Price Trend
15.22% below the market average15.22% below the market average15.22% below the market average15.22% below the market average15.22% below the market average
Sector averageSector averageSector averageSector averageSector average
Income Not Available
Growth
68.03% above the market average68.03% above the market average68.03% above the market average68.03% above the market average68.03% above the market average
75.76% above the sector average75.76% above the sector average75.76% above the sector average75.76% above the sector average75.76% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 1
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

NCYT Dividends

No dividends found

Trades for 30-Jul-2021

Time Volume / Share Price
16:35 130 @ 325.50p
16:29 109 @ 328.34p
16:29 33 @ 328.40p
16:29 500 @ 328.30p
16:29 500 @ 328.20p

NCYT Key Personnel

CEO Graham Mullis

Top of Page